Atlas Trials

The Phase I Clinical Trial of Booster Vaccination of Adenovirus Type-5 Vectored COVID-19 Vaccine

Clinical trial NCT04568811 · COMPLETED

Trial details

NCT number
NCT04568811
Sponsor
Jiangsu Province Centers for Disease Control and Prevention
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Adenovirus Type-5 Vectored COVID-19 Vaccine
Start date
2020-09-26
Primary completion
2020-10-25
Enrollment
89

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.